VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value ($000): $680,145 (100.0% shares, 0.0% debt)

Holdings (25)

— CONSTELLATION PHARMACEUTICAL 17.0%

Value ($000) $115,686 Shares 4,016,873 Est. Cost $31.43 Unrealized —

OLMA OLEMA PHARMACEUTICALS INC 10.9%

Value ($000) $73,860 Shares 1,536,193 Est. Cost $46.89 Unrealized 0.0%

— TRILLIUM THERAPEUTICS INC 8.7%

Value ($000) $59,428 Shares 4,040,000 Est. Cost $4.63 Unrealized —

— KINNATE BIOPHARMA INC 8.6%

Value ($000) $58,596 Shares 1,473,014 Est. Cost $39.78 Unrealized —

— ATHIRA PHARMA INC 8.5%

Value ($000) $57,938 Shares 1,691,623 Est. Cost $20.05 Unrealized —

ALT ALTIMMUNE INC 7.5%

Value ($000) $50,760 Shares 4,500,000 Est. Cost $5.49 Unrealized +114.5%

KROS KEROS THERAPEUTICS INC 7.0%

Value ($000) $47,424 Shares 672,306 Est. Cost $30.81 Unrealized +104.5%

— MARINUS PHARMACEUTICALS INC 4.6%

Value ($000) $31,585 Shares 2,588,941 Est. Cost $12.20 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 3.6%

Value ($000) $24,803 Shares 1,115,255 Est. Cost $17.65 Unrealized +17.5%

RLMD RELMADA THERAPEUTICS INC 3.2%

Value ($000) $21,437 Shares 668,440 Est. Cost $40.32 Unrealized -14.8%

KURA KURA ONCOLOGY INC 2.8%

Value ($000) $18,780 Shares 575,000 Est. Cost $14.42 Unrealized +143.6%

— VISTAGEN THERAPEUTICS INC 2.7%

Value ($000) $18,158 Shares 9,360,000 Est. Cost $1.94 Unrealized —

CLDX CELLDEX THERAPEUTICS INC 2.1%

Value ($000) $14,016 Shares 800,000 Est. Cost $11.71 Unrealized +53.6%

— SURFACE ONCOLOGY INC 2.0%

Value ($000) $13,332 Shares 1,442,895 Est. Cost $6.56 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 1.9%

Value ($000) $12,648 Shares 1,954,932 Est. Cost $4.22 Unrealized 0.0%

COGT COGENT BIOSCIENCES INC 1.8%

Value ($000) $12,227 Shares 1,088,817 Est. Cost $10.99 Unrealized 0.0%

— ALIGOS THERAPEUTICS INC 1.6%

Value ($000) $11,196 Shares 404,906 Est. Cost $27.65 Unrealized —

GRTX GALERA THERAPEUTICS INC 1.4%

Value ($000) $9,390 Shares 917,860 Est. Cost $10.77 Unrealized +1.6%

SPRY SILVERBACK THERAPEUTICS INC 1.0%

Value ($000) $6,951 Shares 150,000 Est. Cost $33.40 Unrealized 0.0%

— BCTG ACQUISITION CORP 0.8%

Value ($000) $5,720 Shares 500,000 Est. Cost $10.36 Unrealized —

— METACRINE INC 0.8%

Value ($000) $5,452 Shares 693,673 Est. Cost $10.21 Unrealized —

— FIVE PRIME THERAPEUTICS INC 0.6%

Value ($000) $4,170 Shares 245,122 Est. Cost $17.01 Unrealized —

BCAB BIOATLA INC 0.5%

Value ($000) $3,401 Shares 100,000 Est. Cost $33.43 Unrealized 0.0%

TSHA TAYSHA GENE THERAPIES INC 0.4%

Value ($000) $2,866 Shares 107,982 Est. Cost $23.52 Unrealized -8.4%

VRDN VIRIDIAN THERAPEUTICS INC 0.0%

Value ($000) $321 Shares 19,495 Est. Cost $15.07 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CONSTELLATION PHARMACEUTICAL	4,016,873	$115,686	17.0%	$31.43	—	COM	210373106
OLMA	OLEMA PHARMACEUTICALS INC	1,536,193	$73,860	10.9%	$46.89	0.0%	COM	68062P106
—	TRILLIUM THERAPEUTICS INC	4,040,000	$59,428	8.7%	$4.63	—	COM	89620X506
—	KINNATE BIOPHARMA INC	1,473,014	$58,596	8.6%	$39.78	—	COM	49705R105
—	ATHIRA PHARMA INC	1,691,623	$57,938	8.5%	$20.05	—	COM	04746L104
ALT	ALTIMMUNE INC	4,500,000	$50,760	7.5%	$5.49	+114.5%	COM	02155H200
KROS	KEROS THERAPEUTICS INC	672,306	$47,424	7.0%	$30.81	+104.5%	COM	492327101
—	MARINUS PHARMACEUTICALS INC	2,588,941	$31,585	4.6%	$12.20	—	COM	56854Q200
SNDX	SYNDAX PHARMACEUTICALS INC	1,115,255	$24,803	3.6%	$17.65	+17.5%	COM	87164F105
RLMD	RELMADA THERAPEUTICS INC	668,440	$21,437	3.2%	$40.32	-14.8%	COM	75955J402
KURA	KURA ONCOLOGY INC	575,000	$18,780	2.8%	$14.42	+143.6%	COM	50127T109
—	VISTAGEN THERAPEUTICS INC	9,360,000	$18,158	2.7%	$1.94	—	COM	92840H202
CLDX	CELLDEX THERAPEUTICS INC	800,000	$14,016	2.1%	$11.71	+53.6%	COM	15117B202
—	SURFACE ONCOLOGY INC	1,442,895	$13,332	2.0%	$6.56	—	COM	86877M209
ACRS	ACLARIS THERAPEUTICS INC	1,954,932	$12,648	1.9%	$4.22	0.0%	COM	00461U105
COGT	COGENT BIOSCIENCES INC	1,088,817	$12,227	1.8%	$10.99	0.0%	COM	19240Q201
—	ALIGOS THERAPEUTICS INC	404,906	$11,196	1.6%	$27.65	—	COM	01626L105
GRTX	GALERA THERAPEUTICS INC	917,860	$9,390	1.4%	$10.77	+1.6%	COM	36338D108
SPRY	SILVERBACK THERAPEUTICS INC	150,000	$6,951	1.0%	$33.40	0.0%	COM	82835W108
—	BCTG ACQUISITION CORP	500,000	$5,720	0.8%	$10.36	—	COM	05492W103
—	METACRINE INC	693,673	$5,452	0.8%	$10.21	—	COM	59101E103
—	FIVE PRIME THERAPEUTICS INC	245,122	$4,170	0.6%	$17.01	—	COM	33830X104
BCAB	BIOATLA INC	100,000	$3,401	0.5%	$33.43	0.0%	COM	09077B104
TSHA	TAYSHA GENE THERAPIES INC	107,982	$2,866	0.4%	$23.52	-8.4%	COM SHS	877619106
VRDN	VIRIDIAN THERAPEUTICS INC	19,495	$321	0.0%	$15.07	0.0%	COM	92790C104